Clinical Trial Update: Efficacy of FOLFOX+Bevacizumab in Combination With Irinotecan in the Treatment of Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating FOLFOX + Bevacizumab in combination with Irinotecan for metastatic colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• FOLFOX
• Irinotecan (Irinotecan)

Snippet

Sponsor: Martin-Luther-Universität Halle-Wittenberg | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED